| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a135a933620c99beab01d4ac785d25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55df1fc5fe895703852d0f7c8aeb2e7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee283fc1222f905ba051eea56fdc8cce |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D273-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D273-00 |
| filingDate |
2021-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ec8a1b64374cd56db7c5da84fe8c4e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d1cbab4d7b0fea8b836dd7d24916389
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25a005b7c8a56582ec2bd98276c10868
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa18ecdad1a78e3c62878f1bff44ee14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09c87b0823e5148c888cbc4b78fc6294
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b8b427a263cc8c180fe60c43e691562
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cac880e1977a4bc35b4340d92b58bef |
| publicationDate |
2021-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021168567-A1 |
| titleOfInvention |
Chelator compositions for radiometals and methods of using same |
| abstract |
A chelator having the general structure (I) for chelating radiometals such as 225Ac under mild conditions is provided. (I) The chelator can be coupled to a biological targeting moiety to facilitate targeted delivery of the chelated radiometal in a mammalian subject. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114807636-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023098920-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2022402959-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023190402-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115286697-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114807636-A |
| priorityDate |
2020-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |